NCT04067583已完成不适用
Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe: A Follow-up Physician Survey
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 454
- 试验地点
- 1
- 主要终点
- Percentage of physicians responding correctly to each individual knowledge question
研究概览
简要总结
With this follow up physician survey researcher want to collect the same data from all participants of the study using a highly structured questionnaire. The questionnaire will gather information related to physician characteristics and experience with Aflibercept, as well as assess physicians' knowledge and understanding of storage and preparation, proper injection technique, and the risks associated with Aflibercept injection into the eye (intravitreal injection). Analysis will be done using descriptive statistics.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Has signed informed consent
- •Is a licensed and practicing ophthalmologist
- •Has prescribed and/or administered aflibercept to at least one patient in the past 6 months
排除标准
- 未提供
结局指标
主要结局
Percentage of physicians responding correctly to each individual knowledge question
时间窗: Up to 1 year
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Risk Minimisation Study for Diane-35 and Its GenericsAcne VulgarisNCT02410031Bayer759
已完成
不适用
Retrospective Safety Survey In Patients Included In NV1FGF Clinical TrialsPeripheral Arterial Occlusive DiseaseNCT01135797Sanofi164
已完成
不适用
Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for AfliberceptMacular DegenerationNCT02615496Bayer716
已完成
不适用
Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial FibrillationAtrial FibrillationNCT02433366Boehringer Ingelheim1,213
已完成
不适用
Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in CanadaAge-related Macular Degeneration (AMD)Central Retinal Vein Occlusion (CRVO)Diabetic Macular Edema (DME)NCT02585401Bayer99
